4
Changes in Ownership
Neurogene Inc. Filed Acc 0001209191-15-003940
Options or other derivatives
- VP Global Regulatory & Quality acquired 35,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mitchell David Chilton · VP Global Regulatory & Quality
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-01-11 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +35,000 | $9.51 | 2025-01-10 | 35,000 | 35,000 | D |
Loading xslF345X03/doc4.xml…